Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ACP1 | P24666 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ESPL1 | Q14674 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1026447 | 0.94 | CYP19A1 (0.62) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| Nitrogen SCHEMBL27917117 | 0.90 | CYP19A1 (0.56) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| Benzene SCHEMBL27782128 | 0.90 | CYP19A1 (0.56) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| SCHEMBL19026582 | 0.87 | CYP19A1 (0.68) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| SCHEMBL1863964 | 0.84 | ALDH1A1 (0.52) | CYP19A1ALDH1A1TSHRCYP3A4LMNA | |
| SCHEMBL220173 | 0.84 | LMNA (0.47) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| SCHEMBL2649497 | 0.84 | CYP19A1 (0.44) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| SCHEMBL4432251 | 0.84 | CYP19A1 (0.44) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| SCHEMBL219621 | 0.84 | ALDH1A1 (0.50) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 | |
| SCHEMBL2013681 | 0.84 | ALDH1A1 (0.50) | CYP19A1ALDH1A1TSHRCYP3A4ACP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504446-A | One-pot method for preparing diphenyl aniline | 西安近代化学研究所 | 2025-02-25 | — | — | CN | claimed |
| CN-113092384-B | Preparation and detection method of micro-fluidic paper chip for rapidly detecting potassium in blood | 中国人民解放军南部战区空军医院 | 2022-06-17 | — | — | CN | claimed |
| CN-105542165-A | N-type electrochromic polymer material and preparation method thereof | UNIV SOUTH CHINA TECH | 2016-05-04 | — | — | CN | claimed |
| CN-122036690-A | Heteroaromatic ring compound, pharmaceutical composition and application thereof | 马应龙药业集团股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4602028-A1 | CBL-B MODULATORS AND USES THEREOF | Nimbus Clio, Inc. (US) | 2025-08-20 | — | — | EP | disclosed |
| CN-119504446-A | One-pot method for preparing diphenyl aniline | 西安近代化学研究所 | 2025-02-25 | — | — | CN | disclosed |
| CN-119504446-A | One-pot method for preparing diphenyl aniline | 西安近代化学研究所 | 2025-02-25 | — | — | CN | disclosed |
| US-20240228482-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER | HOTSPOT THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
| WO-2024081311-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. (US) | 2024-04-18 | — | — | WO | disclosed |
| CN-117751115-A | Compounds, compositions, and methods of treating cancer | 热点治疗公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117147540-A | Blood potassium detection device | 自贡市第四人民医院(自贡市急救中心) | 2023-12-01 | — | — | CN | disclosed |
| US-6316450-B1 | PIPERAZINE COMPOUNDS FOR TREATING DEPRESSION AND ANXIETY | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-11-13 | — | — | US | disclosed |
| EP-0994862-A2 | SULPHONAMIDE DERIVATIVES BEING 5-HT6 RECEPTOR ANTAGONISTS AND PROCESS FOR THEIR PREPARATION | SMITHKLINE BEECHAM PLC (GB) | 2000-04-26 | — | — | EP | disclosed |
| WO-1999002502-A2 | SULPHONAMIDE DERIVATIVES BEING 5-HT6 RECEPTOR ANTAGONISTS AND PROCESS FOR THEIR PREPARATION | SMITHKLINE BEECHAM PLC (GB) | 1999-01-21 | — | — | WO | disclosed |
| US-5652239-A | TREATMENT OF STROKES, ISCHEMIC ATTACK, ANTAGONISTS OF EXCITATORY AMINO ACIDS GLUTAMATE AND ASPARTATE | IMPERIAL CHEMICAL COMPANY (GB) | 1997-07-29 | — | — | US | disclosed |
| EP-0512817-B1 | Pyridazinedione derivatives, their preparation and pharmaceutical applications | ZENECA LTD (GB) | 1997-02-19 | — | — | EP | disclosed |
| EP-0512817-A1 | Pyridazinedione derivatives, their preparation and pharmaceutical applications | ZENECA LIMITED (GB) | 1992-11-11 | — | — | EP | disclosed |
| US-4172098-A | REACTION OF A HALOAMINOBENZOIC ACID WITH AN ALCOHOL AND NITROSYLATING AGENT IN THE PRESCENCE OF AN ACID AND WATER | BASF AKTIENGESELLSCHAFT (DE) | 1979-10-23 | — | — | US | disclosed |
| US-4053527-A | REACTING HALONITROANILINES WITH ALCOHOLS AND NITROSATING AGENTS ION | BASF AKTIENGESELLSCHAFT (DT) | 1977-10-11 | — | — | US | disclosed |
| US-4020107-A | ACIDIC PHOSPHORUS COMPOUND DEHALOGENATION INHIBITOR | E. I. DU PONT DE NEMOURS AND CO. (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228482-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER | TP53, CASP3, BAX | CYP19A1 275/4885ALDH1A1 338/4885TSHR 4813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.